The Role of Endoplasmic Reticulum in Lipotoxicity during Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Pathogenesis

被引:16
|
作者
Venkatesan, Nanditha [1 ]
Doskey, Luke C. [2 ]
Malhi, Harmeet [1 ,3 ]
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA
[2] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA
[3] Mayo Clin, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA
来源
AMERICAN JOURNAL OF PATHOLOGY | 2023年 / 193卷 / 12期
关键词
SIGNAL RECOGNITION PROTEIN; INDUCED ER STRESS; UNFOLDED PROTEIN; LIPID DROPLETS; EXTRACELLULAR VESICLES; HEPATIC LIPOTOXICITY; CONTACT SITES; MEMBRANE; TRANSLOCATION; CERAMIDE;
D O I
10.1016/j.ajpath.2023.08.007
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Perturbations in lipid and protein homeostasis induce endoplasmic reticulum (ER) stress in metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease. Lipotoxic and proteotoxic stress can activate the unfolded protein response (UPR) transducers: inositol requiring enzyme1a, PKR-like ER kinase, and activating transcription factor 6a. Collectively, these pathways induce expression of genes that encode functions to resolve the protein folding defect and ER stress by increasing the protein folding capacity of the ER and degradation of misfolded proteins. The ER is also intimately connected with lipid metabolism, including de novo ceramide synthesis, phospholipid and cholesterol synthesis, and lipid droplet formation. Following their activation, the UPR transducers also regulate lipogenic pathways in the liver. With persistent ER stress, cellular adaptation fails, resulting in hepatocyte apoptosis, a pathological marker of liver disease. In addition to the ER-nucleus signaling activated by the UPR, the ER can interact with other organelles via membrane contact sites. Modulating intracellular communication between ER and endosomes, lipid droplets, and mitochondria to restore ER homeostasis could have therapeutic efficacy in ameliorating liver disease. Recent studies have also demonstrated that cells can convey ER stress by the release of extracellular vesicles. This review discusses lipotoxic ER stress and the central role of the ER in communicating ER stress to other intracellular organelles in MASLD pathogenesis. (Am J Pathol 2023, 193: 1887-1899; https://doi.org/10.1016/j.ajpath.2023.08.007)
引用
收藏
页码:1887 / 1899
页数:13
相关论文
共 50 条
  • [21] Myokines and Their Potential Protective Role Against Oxidative Stress in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Bucarey, Jose Luis
    Trujillo-Gonzalez, Isis
    Paules, Evan M.
    Espinosa, Alejandra
    ANTIOXIDANTS, 2024, 13 (11)
  • [22] Thyroid Hormone and Mitochondrial Dysfunction: Therapeutic Implications for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Ramanathan, Raghu
    Patwa, Sohum A.
    Ali, Ahmad Hassan
    Ibdah, Jamal A.
    CELLS, 2023, 12 (24)
  • [23] Mitigating Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): The Role of Bioactive Phytoconstituents in Indian Culinary Spices
    Barbhuiya, Pervej Alom
    Ahmed, Ameena
    Dutta, Partha Pratim
    Sen, Saikat
    Pathak, Manash Pratim
    CURRENT NUTRITION REPORTS, 2025, 14 (01)
  • [24] Prognostic role of ELF test compared to liver biopsy in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
    Liguori, A.
    D'Ambrosio, F.
    Viceconti, N.
    Termite, F.
    Petrucci, L.
    Beschi, R.
    Orienti, M.
    Galletti, S.
    Cardinali, S.
    Riccardi, L.
    Garcovich, M.
    Pizzolante, F.
    De Matthaeis, N.
    Zocco, M. A.
    Ainora, M. E.
    Giustiniani, M. C.
    Marrone, G.
    Biolato, M.
    Cefalo, C.
    Vecchio, F. M.
    Grieco, A.
    Urbani, A.
    Sanguinetti, M.
    Gasbarrini, A.
    Miele, L.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S12 - S12
  • [25] THE ROLE OF REVISIONAL ENDOSCOPIC SLEEVE GASTROPLASTY (RESG) TO TREAT METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Hedjoudje, Abdellah
    Hoff, Anna C.
    Nunes, Gabriel C.
    Barrichello, Sergio
    Huang, Yuting
    Patel, Tushar
    Kumbhari, Vivek
    Badurdeen, Dilhana S.
    GASTROENTEROLOGY, 2024, 166 (05) : S1638 - S1639
  • [26] Evaluation of metabolic dysfunction-associated steatotic liver disease (MASLD) terminology in different clinical settings
    Iruzubieta, Paula
    Santos-Laso, Alvaro
    Arias-Loste, Maria Teresa
    Calleja, Jose Luis
    Crespo, Javier
    JOURNAL OF HEPATOLOGY, 2024, 80 (03) : e121 - e123
  • [27] Converging Pathways between Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Diabetes in Children
    Faienza, Maria Felicia
    Farella, Ilaria
    Khalil, Mohamad
    Portincasa, Piero
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (18)
  • [28] Genome-wide Association Study on Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
    Darlay, Rebecca
    Zatorska, Michalina
    Worthington, Sarah
    Anstee, Quentin M.
    Daly, Ann K.
    Cordell, Heather J.
    GENETIC EPIDEMIOLOGY, 2024, 48 (07) : 352 - 352
  • [29] Epidemiology of metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-related liver disease (ALD)
    Wong, Robert J.
    METABOLISM AND TARGET ORGAN DAMAGE, 2024, 4 (04):
  • [30] Novel insights of phenylalanine in Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) and cardiovascular complications
    Liu, J.
    Chen, Y.
    Qian, J.
    Cui, R.
    Demirkan, A.
    Zheng, Y.
    EUROPEAN HEART JOURNAL, 2024, 45